Cargando…
Improving the Assessment of Neonatal Abstinence Syndrome (NAS)
Neonatal Abstinence Syndrome (NAS) is a public health problem of epidemic proportions. The Finnegan Neonatal Abstinence Scoring System (FNASS) is the tool most widely used to evaluate NAS. However, it is limited by its lack of interrater reliability and standardized approach. Surveys to evaluate the...
Autores principales: | Chin Foo, Claire A., Dansereau, Lynne M., Hawes, Katheleen, Oliveira, Erica L., Lester, Barry M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394483/ https://www.ncbi.nlm.nih.gov/pubmed/34438576 http://dx.doi.org/10.3390/children8080685 |
Ejemplares similares
-
Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)
por: Moreno-Ramos, Miriam, et al.
Publicado: (2021) -
59473 Clinical and demographic predictors of the need for pharmacotherapy in Neonatal Abstinence Syndrome (NAS)
por: Bibi, Shawana, et al.
Publicado: (2021) -
Review of the assessment and management of neonatal abstinence syndrome
por: Bagley, Sarah Mary, et al.
Publicado: (2014) -
Association of a Simplified Finnegan Neonatal Abstinence Scoring Tool With the Need for Pharmacologic Treatment for Neonatal Abstinence Syndrome
por: Devlin, Lori A., et al.
Publicado: (2020) -
Polygenic Risk Scores and the Need for Pharmacotherapy in Neonatal Abstinence Syndrome
por: Bibi, Shawana, et al.
Publicado: (2023)